ETS2 and neoplasm: Research has demonstrated that synthetic TFOs can directly bind to the Ets2 promoter sequence, with Ets2-TFO able to suppress the expression of endogenous genes and the activity of the Ets2 promoter in prostate cancer29, suggesting that this RNA–DNA triplex structure may play an important role in tumor progression.